Laurie E. Ailles

610 University Ave, M5G 1L7
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Positron Emission Tomography/Computed Tomography (PET/CT) and Radioimmunotherapy of Head and Neck Cancer Patient Derived Xenografts in NRG Mice with Theranostic [64Cu]Cu-DOTA-Panitumumab F(ab')2 and [177Lu]Lu-DOTA-Panitumumab F(ab')2.

Positron Emission Tomography/Computed Tomography (PET/CT) and Radioimmunotherapy of Head and Neck Cancer Patient Derived Xenografts in NRG Mice with Theranostic [64Cu]Cu-DOTA-Panitumumab F(ab')2 and [177Lu]Lu-DOTA-Panitumumab F(ab')2.

Journal: Molecular pharmaceutics

Published: October 21, 2025

In vitro and in vivo derived macrophages occupy distinct phenotypic states.

In vitro and in vivo derived macrophages occupy distinct phenotypic states.

Journal: bioRxiv : the preprint server for biology

Published: September 26, 2025

SULF1 in Cancer Associated Fibroblasts Promotes Invasion in Head and Neck Cancer Cell Lines.

SULF1 in Cancer Associated Fibroblasts Promotes Invasion in Head and Neck Cancer Cell Lines.

Journal: Cancer medicine

Published: August 21, 2025

VHL Gene Restoration Supports RCC Reprogramming to iPSCs but Does Not Ensure Line Stability.

VHL Gene Restoration Supports RCC Reprogramming to iPSCs but Does Not Ensure Line Stability.

Journal: Cancers

Published: July 31, 2025

Picosecond infrared laser mass spectrometry for 10-second identification of lymphoproliferative imposter tumours in patient-derived xenografts.

Picosecond infrared laser mass spectrometry for 10-second identification of lymphoproliferative imposter tumours in patient-derived xenografts.

Journal: Scientific reports

Published: July 30, 2025

NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma.

NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma.

Journal: European thyroid journal

Published: February 19, 2025

MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma.

MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: February 06, 2025

Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer.

Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer.

Journal: Cell reports. Medicine

Published: January 15, 2025

Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target.

Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target.

Journal: Cell reports. Medicine

Published: January 09, 2025

RASSF1A loss in ccRCC: genomic instability and the role of chromosome 3p.

RASSF1A loss in ccRCC: genomic instability and the role of chromosome 3p.

Journal: Kidney international

Published: January 08, 2025

PRMT1 inhibitor MS023 suppresses RNA splicing to sensitize small cell lung cancer to DNA damaging agents.

PRMT1 inhibitor MS023 suppresses RNA splicing to sensitize small cell lung cancer to DNA damaging agents.

Journal: Neoplasia (New York, N.Y.)

Published: November 29, 2024

Comparative single-cell transcriptomic profiling of patient-derived renal carcinoma cells in cellular and animal models of kidney cancer.

Comparative single-cell transcriptomic profiling of patient-derived renal carcinoma cells in cellular and animal models of kidney cancer.

Journal: FEBS open bio

Published: September 05, 2024

Showing 1-12 of 74

Last Updated: 09/26/2026